What Causes Heart Palpitations in Perimenopause with Hypothyroidism?

What Causes Heart Palpitations in Perimenopause with Hypothyroidism?

Yes, perimenopause and hypothyroidism together genuinely increase your risk of heart palpitations beyond what either condition does alone. Estrogen fluctuations destabilize the autonomic nervous system while low thyroid hormone slows cardiac conduction — the combination can produce racing, skipping, or pounding beats even when your TSH looks "normal." The exception: if your thyroid is well-managed and estrogen swings are mild, palpitations may be minimal.

---

Why Perimenopause Triggers Palpitations in the First Place

Perimenopause isn't a gradual, linear decline in estrogen — it's an erratic oscillation. Estrogen levels can spike dramatically, then crash within days, and this volatility directly affects cardiac rhythm. Estrogen receptors are found throughout the heart and in the sinoatrial node, the structure responsible for setting heart rate. When estrogen surges, it can shorten the QT interval and increase adrenergic sensitivity; when it drops, it can trigger vasomotor symptoms — hot flashes — that themselves spike adrenaline and heart rate (Stevenson 2001; PMID: 11242600).

Separately, declining estrogen reduces magnesium retention at the cellular level. Magnesium is critical for regulating calcium influx in cardiac muscle cells — low intracellular magnesium is associated with both atrial ectopic beats and increased sensitivity to adrenaline. Many perimenopausal women are already depleted without realizing it. If you're also dealing with heart palpitations that seem tied to your hormonal cycle, the estrogen-magnesium connection is one of the first mechanisms worth ruling in or out.

Vasomotor episodes — hot flashes and night sweats — cause abrupt surges in sympathetic nervous system activity. Heart rate can jump 15–20 beats per minute during a single hot flash, which is enough for many women to register as a palpitation (Thurston et al., Menopause 2011; PMID: 21900849). For women already prone to palpitations from thyroid dysfunction, this sympathetic amplification pushes the symptom from occasional to frequent.

---

Hypothyroidism Root Causes That Make Palpitations Worse

Counterintuitively, hypothyroidism — a condition of low thyroid hormone — can cause palpitations, not just hyperthyroidism. Here's why: when thyroid hormone is low, the heart muscle becomes less efficient, stroke volume drops, and the cardiovascular system compensates by increasing sympathetic drive to maintain cardiac output (Klein & Ojamaa, NEJM 2001; PMID: 11136262). This compensatory sympathetic activation is what drives the palpitation sensation — the heart is working harder to push the same amount of blood.

The most common root causes of hypothyroidism in perimenopausal women include:

• Hashimoto's thyroiditis — autoimmune destruction of thyroid tissue, the cause in roughly 90% of primary hypothyroidism cases in developed countries. Thyroid peroxidase (TPO) antibodies and thyroglobulin (TG) antibodies are the key markers.
• Iodine insufficiency — rare in populations with iodized salt but relevant in women who avoid processed foods and use non-iodized sea salt exclusively.
• Selenium deficiency — selenium is required for the conversion of T4 to the active T3 hormone via deiodinase enzymes. Low selenium means high reverse T3 and functional hypothyroid symptoms even when TSH is within range (Gärtner et al., Journal of Clinical Endocrinology & Metabolism 2002; PMID: 11932302).
• Estrogen excess relative to progesterone — elevated estrogen raises thyroid-binding globulin (TBG), which binds more circulating T4 and T3, reducing the free fractions available to tissues. This is a significant but under-discussed link between perimenopause and worsening thyroid symptoms.
• Gut permeability and chronic low-grade inflammation — elevated CRP and dysbiosis are increasingly associated with impaired thyroid hormone signaling. If you've had high CRP on a blood panel, that inflammation may be directly affecting both thyroid function and cardiac rhythm.

---

The Biomarkers You Need — Not Just TSH

A TSH-only panel catches overt hypothyroidism but misses subclinical thyroid dysfunction, poor T4-to-T3 conversion, and autoimmune activity — all of which can produce palpitations without a flagged TSH. Here is a more complete picture:

Low ferritin is a particularly underappreciated driver: iron is a cofactor for thyroid peroxidase, the enzyme that synthesizes thyroid hormone. Women with heavy periods entering perimenopause often have suppressed ferritin without frank anemia, which impairs both thyroid hormone production and oxygen delivery — a dual mechanism for fatigue and palpitations. For a deeper look at what causes insomnia in perimenopause, the same hormonal and thyroid markers often appear, since sleep disruption and palpitations frequently share the same root.

---

How Stress Amplifies Both Conditions — and What to Do About It

Stress deserves its own section here because it acts as a force multiplier for both perimenopause-related palpitations and hypothyroidism. Cortisol has a bidirectional relationship with the thyroid: acutely elevated cortisol suppresses TSH secretion and promotes conversion of T4 into the inactive reverse T3 rather than active T3 (Samuels et al., Journal of Clinical Endocrinology & Metabolism 2007; PMID: 17299077). Simultaneously, chronically elevated cortisol accelerates estrogen clearance, worsens progesterone deficiency, and raises adrenergic tone — all of which increase palpitation frequency.

For women dealing with perimenopause and hypothyroidism together, common stress-reduction strategies that have clinical backing include:

1. Ashwagandha (KSM-66 extract, 600 mg/day): A randomized controlled trial of 64 adults found that KSM-66 reduced serum cortisol by 27.9% versus placebo over 60 days (Chandrasekhar et al., Indian Journal of Psychological Medicine 2012; PMID: 23439798). Separately, ashwagandha has shown modest TSH-normalizing effects in subclinical hypothyroid patients, possibly through direct thyroid stimulation.
2. Rhodiola Rosea (standardized extract, 200–400 mg/day): Supports HPA axis regulation and reduces perceived stress — particularly useful for women experiencing burnout-pattern fatigue alongside thyroid dysfunction.
3. Sleep architecture: Fragmented sleep, which is extremely common when night sweats and palpitations coexist, itself elevates cortisol and suppresses thyroid conversion. Prioritizing sleep continuity is not optional — it's mechanistically necessary.
4. Dietary magnesium and supplemental magnesium glycinate: Magnesium suppresses the HPA axis response, reduces adrenaline-driven palpitations, and supports both sleep and cardiac conduction simultaneously.

Addressing stress isn't separate from treating palpitations in this population — it's a core part of the protocol. This overlap also helps explain why chronic fatigue and palpitations often travel together in perimenopausal women with thyroid issues.

---

Elevated Blood Pressure as an Overlapping Risk

High blood pressure is more common in perimenopause than most women expect — estrogen's vasodilatory effects diminish, arterial stiffness increases, and the renin-angiotensin-aldosterone system becomes less regulated. Hypothyroidism compounds this: low T3 reduces endothelial nitric oxide production, increases systemic vascular resistance, and elevates diastolic blood pressure specifically. The combination raises cardiac workload and can make existing palpitations feel more intense or more alarming, particularly during episodes of sympathetic activation.

Key modifiable contributors to elevated blood pressure in this population:

• Sodium-potassium imbalance: Low potassium relative to sodium intake is a primary driver of blood pressure elevation. Women with fatigue, night sweats, or adrenal stress often have suboptimal potassium levels. For more on testing this specifically, the guide on potassium deficiency causes and testing is worth reviewing before supplementing.
• Low Omega-3 index: EPA and DHA reduce triglycerides, lower resting heart rate, and modestly reduce systolic blood pressure at doses of 2–3 g/day of combined EPA+DHA (Mozaffarian & Wu, Journal of the American College of Cardiology 2011; PMID: 22051327).
• Magnesium deficiency: Magnesium acts as a natural calcium channel blocker in vascular smooth muscle. Replenishing magnesium (especially as glycinate or malate for bioavailability) consistently lowers blood pressure in deficient adults across multiple meta-analyses.

---

What This Means for Your Formula

When perimenopause and hypothyroidism converge to produce palpitations, the supplement strategy needs to address multiple mechanisms simultaneously — not just reach for a general "women's formula." Ones analyzes blood work and health history to identify which of these drivers are actually active for you, then builds a formula calibrated to your specific gaps.

For women in this clinical picture, Ones commonly includes:

• Magnesium Glycinate (from the Magnesium Complex blend): Addresses the magnesium depletion that both estrogen decline and stress accelerate. Magnesium glycinate is preferentially used for cardiac and nervous system applications given its superior bioavailability and tolerability compared to oxide forms.
• Omega-3 (EPA/DHA): Included at doses sufficient to meaningfully shift the Omega-3 index, supporting heart rhythm stability, vascular tone, and reducing inflammatory load that can worsen thyroid autoimmunity.
• Ones' Thyroid Support blend: This proprietary System Blend contains selenomethionine at 200 mcg — matching the dose used in the Gärtner 2002 trial that showed significant TPO antibody reduction in Hashimoto's patients — along with iodine, zinc, and supporting cofactors for T4-to-T3 conversion.
• Ashwagandha (KSM-66, 600 mg): Included when the AI identifies elevated perceived stress or cortisol-pattern markers alongside thyroid and hormonal findings, to interrupt the cortisol-rT3 feedback loop.

The formula comes in a 6 or 9-capsule daily plan determined by the AI based on the number of active findings, so the priority stack is always calibrated to your actual capsule budget — not a one-size-fits-all approach.

---

Key Takeaways

• Heart palpitations in perimenopausal women with hypothyroidism typically have at least two simultaneous root causes: erratic estrogen destabilizing cardiac autonomic tone, and low thyroid hormone increasing compensatory sympathetic drive.
• A TSH-only thyroid panel is insufficient — free T3, reverse T3, TPO antibodies, selenium, and ferritin are all relevant to understanding why palpitations are occurring.
• Estrogen's role in raising thyroid-binding globulin means perimenopause itself can worsen functional hypothyroidism even when medication dose hasn't changed.
• Cortisol and stress suppress T4-to-T3 conversion and amplify adrenergic tone — managing HPA axis dysregulation is mechanistically necessary, not optional.
• Magnesium deficiency, low Omega-3 index, and potassium-sodium imbalance are common modifiable contributors to both palpitations and blood pressure elevation in this population.
• Always consult a qualified healthcare provider before adjusting thyroid medication, hormone therapy, or supplement protocols — these systems interact closely and personalized oversight matters.